Sofinnova Investments, Inc. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.72 Billion distributed in 74 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $142M, Vera Therapeutics, Inc. with a value of $120M, Ascendis Pharma A/S with a value of $114M, Aerovate Therapeutics, Inc. with a value of $111M, and Merck & Co., Inc. with a value of $85.9M.

Examining the 13F form we can see an increase of $136M in the current position value, from $1.58B to 1.72B.

Sofinnova Investments, Inc. is based out at Menlo Park, CA

Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.72 Billion
Healthcare: $1.63 Billion
ETFs: $80.7 Million
Basic Materials: $5.94 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 74
  • Current Value $1.72 Billion
  • Prior Value $1.58 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 28 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.


Stay updated on Sofinnova Investments, Inc. with notifications on news.